Understanding the hormonal drivers of fibroid growth is not just academic — it directly informs which lifestyle changes and treatments are most relevant to your situation. This article explains the hormonal mechanisms clearly, without oversimplification.
Estrogen: The Primary Driver
Fibroids are classified as estrogen-sensitive tumours. They express estrogen receptors at higher levels than normal uterine tissue, meaning they respond more strongly to estrogen than the surrounding myometrium. Estrogen promotes fibroid cell proliferation — the growth of new fibroid cells — and inhibits apoptosis (programmed cell death that normally keeps tissue growth in check).
This is why fibroids develop during the reproductive years (when estrogen is high), grow during pregnancy (when estrogen peaks), and typically shrink after menopause (when ovarian estrogen production declines). It is also why hormonal treatments that lower estrogen — such as GnRH agonists — are effective at shrinking fibroids, albeit temporarily.
Progesterone: More Complex Than Expected
For decades, progesterone was assumed to counteract estrogen’s effects on fibroids. The reality is more complicated. Fibroids also express progesterone receptors, and research has shown that progesterone can actually stimulate fibroid cell proliferation — particularly in the luteal phase of the menstrual cycle.
This does not mean progesterone is “bad” for women with fibroids. Progesterone plays many important roles. But it does explain why some women experience symptom worsening in the second half of their cycle, and why the hormonal picture is not as simple as “estrogen bad, progesterone good.”
Estrogen Dominance: The Practical Concept
Estrogen dominance — a state where estrogen is high relative to progesterone — is the hormonal pattern most consistently associated with symptomatic fibroids. This can occur when estrogen is genuinely elevated, when progesterone is low, or both.
Contributing factors include chronic stress (which suppresses progesterone), excess body fat (which produces additional estrogen), poor liver function (which impairs estrogen clearance), and environmental estrogen exposure.
Other Hormonal Factors
Insulin and IGF-1
Insulin-like growth factor 1 (IGF-1) has been shown to stimulate fibroid cell growth. Women with insulin resistance or metabolic syndrome have elevated IGF-1 levels, which may explain the association between these conditions and higher fibroid risk. Managing blood sugar through dietary choices and regular exercise is relevant here.
Prolactin
Some research has identified elevated prolactin levels in women with fibroids. Prolactin is primarily known for its role in lactation, but it also has effects on smooth muscle growth. This relationship is less well understood than the estrogen connection but is an active area of research.
Practical Implications
Understanding the hormonal drivers of fibroid growth points toward the most effective lifestyle approaches: reducing estrogenic load, supporting progesterone balance, managing blood sugar, reducing inflammation, and supporting liver estrogen metabolism. These are not alternative medicine — they are rational responses to well-understood biological mechanisms.
